In addition, in this cancer TDO2 helps to recruit SIRT7 in the chromatin after DNA damage by chemotherapeutic agents, which transiently decreases histone H3K18 acetylation and increases damage signaling and repair [142]. The gene discussed is SIRT7; the disease is cancer.